Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Relationships between time in target range and A1C (25; 26) and number of severe and non-severe hypoglycemic events (27-31) have also been observed.”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [31]
In the citing paper
“Nevertheless, our analysis in people without diabetes are in line with the International Hypoglycaemia Study Group (IHSG) classification for hypoglycaemia, particularly regarding level 1 hypoglycaemia [78].”
From Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review (2022) · cites this paper as [78]
In the citing paper
“The severity of hypoglycemia is not strictly defined by glucose levels, but is characterized by the severity of the associated symptoms of hypoglycemia and risks, as defined by the International Hypoglycemia Study Group [14] (Tables 2 and 3).”
From Hypoglycemia in Adults (2023) · cites this paper as [14]
Citations
Cites
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389
Defining and Reporting Hypoglycemia in Diabetes
American Diabetes Association Workgroup on Hypoglycemia (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1245 · Cited by 1,146
Hypoglycemia and risk of death in critically ill patients
The NICE-SUGAR Study Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204942 · Cited by 1,009 · cited 1×
“NICE-SUGAR trial (23) and, possibly, in”
Bonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933
Heller, S. R., & Cryer, P. E. (1991) · Diabetes · doi:10.2337/diab.40.2.223 · Cited by 531
Dagogo-Jack, S. E., Craft, S., & Cryer, P. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116302 · Cited by 471
Mechanisms of hypoglycemia-associated autonomic failure in diabetes
Cryer, P. E. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1215228 · Cited by 433
Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes.
Cranston, I., Lomas, J., Amiel, S. A., Maran, A., & Macdonald, I. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91336-6 · Cited by 430
Chow, E., Bernjak, A., Williams, S., Fawdry, R. A., Hibbert, S., Freeman, J., Sheridan, P. J., & Heller, S. R. (2014) · Diabetes · doi:10.2337/db13-0468 · Cited by 403
Fanelli, C. G., Epifano, L., Rambotti, A. M., Pampanelli, S., Di Vincenzo, A., Modarelli, F., Lepore, M., Annibale, B., Ciofetta, M., Bottini, P., et al. (1993) · Diabetes · doi:10.2337/diab.42.11.1683 · Cited by 398
Research works printed but not linked: 1
- Cryer, 2001, The prevention and correction of hypoglycemia, 1057
Cited by
Items 301–400 of 615
Marinac, M., Sutphin, J., Hutton, C. T., Klein, K., Sullivan, S., & Mansfield, C. A. (2020) · Patient Preference and Adherence · doi:10.2147/ppa.s262358 · Cited by 9
O’Donnell, H. K., Vigers, T., Johnson, S. B., Pyle, L. L., Gonder-Fredrick, L., Hendrieckx, C., & Driscoll, K. A. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.106792 · Cited by 10
Breaking Barriers With Basal Insulin Biosimilars in Type 2 Diabetes
Heller, S. R., Raposo, J. F., Tofé, S., Hanif, W., Schroner, Z., Down, S., & Blevins, T. (2022) · Clinical Diabetes · doi:10.2337/cd22-0016 · Cited by 9
Cordiner, R. L. M., Bedair, K., Mari, A., & Pearson, E. R. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae033 · Cited by 9
van Meijel, L. A., van den Heuvel-Bens, S. P. W. H., Zimmerman, L. J., Bazelmans, E., Tack, C. J., & de Galan, B. E. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.02.004 · Cited by 10
Iloh, G. U. P., & Amadi, A. (2018) · Journal of Health Research and Reviews · doi:10.4103/jhrr.jhrr_37_17 · Cited by 14
de Valk, H. W., Lablanche, S., Bosi, E., Choudhary, P., Silva, J. D., Castañeda, J., Vorrink, L., de Portu, S., & Cohen, O. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0222 · Cited by 9
Gawrecki, A., Araszkiewicz, A., Szadkowska, A., Biegański, G., Konarski, J. M., Domaszewska, K., Michalak, A., Skowrońska, B., Adamska, A., Naskręt, D., et al. (2019) · Pediatric Exercise Science · doi:10.1123/pes.2018-0264 · Cited by 9
Dynamic response of cerebral blood flow to insulin-induced hypoglycemia
McManus, R., Ioussoufovitch, S., Froats, E., Lawrence, K. S., Uum, S. H. M. V., & Diop, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-77626-6 · Cited by 10
Ling, J., Poon, E. W. M., Yang, A., Yeung, T., Loo, K.-M., Ozaki, R., Ronald, C. W., Luk, A. O. Y., Kong, A. P. S., Chan, J. C. N., et al. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01046-6 · Cited by 9
“0 mmol/ l) hypoglycemic events was reported [9].”
BackgroundLehmann, V. F., Tripyla, A., Herzig, D., Meier, J., Banholzer, N., Maritsch, M., Zehetner, J., Giachino, D., Nett, P. C., Feuerriegel, S., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14456 · Cited by 9
Basille, D., Timmerman, M., Basille-Fantinato, A., Al‐Salameh, A., Fendri, S., & Lalau, J. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109786 · Cited by 9
The Two-Bag Method for Management of Adult Diabetic Ketoacidosis—Experience With 634 Patients
Haas, N. L., Sell, J. J., Cranford, J. A., Korley, F. K., & Bassin, B. S. (2023) · Journal of Intensive Care Medicine · doi:10.1177/08850666231175387 · Cited by 9
Tripyla, A., Ferreira, A., Schönenberger, K. A., Näf, N. H., Inderbitzin, L. E., Prendin, F., Cossu, L., Cappon, G., Facchinetti, A., Herzig, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-0454 · Cited by 10
Diabetesmanagement im Krankenhaus (Update 2019)
Mader, J. K., Aberer, F., Brix, J. M., Föger, B., Hochfellner, D. A., Kietaibl, A.-T., Ludvik, B., Resl, M., Ress-Winkel, C., Stechemesser, L., et al. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-019-1447-z · Cited by 11
Majumder, A., RoyChaudhuri, S., & Sanyal, D. (2019) · Cureus · doi:10.7759/cureus.6191 · Cited by 9
Olveira, G., Abuín, J., López, R., Herránz, S., García‐Almeida, J. M., García-Malpartida, K., Ferrer, M., Cáncer, E., Pérez, L. M. L., Álvarez, J., et al. (2020) · Endocrine Practice · doi:10.4158/ep-2019-0482 · Cited by 10
Stefenon, P., da Silveira, A. L. M., Giaretta, L. S., Leitão, C. B., & Bauer, A. C. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-0521-z · Cited by 9
van Meijel, L. A., Tack, C. J., & de Galan, B. E. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14505 · Cited by 10
Tentolouris, A., Eleftheriadou, I., & Tentolouris, N. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2017.12.28 · Cited by 9
Shehadeh, N., Galassetti, P. R., Iqbal, N., Karlsson, C., Monyak, J. T., Ostridge, J., Bolin, M., & Barrett, T. G. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae723 · Cited by 11
“Hypoglycemia was defined according to American Diabetes Association and International Society for Pediatric and Adolescent Diabetes Classification (17, 18).”
Frequent hypoglycemia during hemodialysis in ESRD patients leads to higher risk of death
Shi, Y., Wang, T., Ding, Z., Yan, L., Yao, C., & Qian, H. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2484471 · Cited by 9
“…the selection of this glucose threshold was based on the definition of hypoglycemia by the american Diabetes association and previous publications [13,14]. in this study, for patients who have suspected hypoglycemia symptoms during dialysis, we tested random blood glucose to evaluate whether…”
Renard, É., Riveline, J., Hanaire, H. P., & Guerci, B. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14644 · Cited by 10
Prendin, F., Cappon, G., Tripyla, A., Herzig, D., Bally, L., & Facchinetti, A. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14783 · Cited by 8
Mellor, J., Kuznetsov, D., Heller, S. R., Gall, M.-A., Rosilio, M., Amiel, S. A., Ibberson, M. R., McGurnaghan, S. J., Blackbourn, L. A. K., Berthon, W., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06177-6 · Cited by 12
Hajjaji, I. M., Eshwihdi, N., & Barrowman, N. (2019) · International Journal of Clinical Practice · doi:10.1111/ijcp.13348 · Cited by 8
Blank, S. P., Blank, R. M., & Campbell, L. T. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.06.001 · Cited by 8
Eissa, M. R., Benaissa, M., Good, T., Zheng, H., Gianfrancesco, C., Ferguson, C., & Elliott, J. (2022) · Diabetic Medicine · doi:10.1111/dme.14972 · Cited by 8
Lee, B., Min, K. W., Hong, E., Ku, B. J., Kang, J. G., Chon, S., Lee, W., Park, M. K., Kim, J. H., Kim, S. Y., et al. (2023) · Endocrinology and Metabolism · doi:10.3803/enm.2023.1688 · Cited by 9
Davis, T. M. E., Bruce, D. G., Finn, J., Curtis, B. H., Barraclough, H., & Davis, W. A. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13568 · Cited by 8
Matthews, D. R., Paldánius, P. M., Stümvoll, M., Han, J., Bader, G., Chiang, Y., Proot, P., & Prato, S. D. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13800 · Cited by 9
Ali, N., Janssen, A. W. M., Jaeger, M., de Wijer, L. V., van der Heijden, W., ter Horst, R., Vart, P., van Gool, A. J., Joosten, L. A. B., Netea, M. G., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14172 · Cited by 9
“Adults with type 1 diabetes experience, on average, two hypoglycaemic events per week and annually one episode of severe hypoglycaemia (SH),(2) defined as an event requiring external assistance because of cognitive decline.(3) Recurrent hypoglycaemia can lead to impaired awareness of hypoglycaemia (IAH), defined as di…”
BackgroundSantos, C. A. Q., Conover, C. S., Shehab, N., Geller, A. I., Guerra, Y. S., Kramer, H., Kosacz, N. M., Zhang, H., Budnitz, D. S., & Trick, W. E. (2020) · Medical Care · doi:10.1097/mlr.0000000000001398 · Cited by 8
IGUDESMAN, D. A., Crandell, J., Zhong, V. W., Sarteau, A. C., Kahkoska, A. R., Corbin, K. D., Pratley, R. E., Kosorok, M. R., Maahs, D. M., & Mayer‐Davis, E. J. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13132 · Cited by 8
Plum‐Mörschel, L., Singh, G., Murugesan, S. M. N., Marwah, A., Panda, J., Loganathan, S., & Athalye, S. N. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14635 · Cited by 8
YOSHINAGA, R., Ishikawa, S., Ayukawa, K., & Doi, Y. (2018) · Diabetes Care · doi:10.2337/dc18-1978 · Cited by 8
Zuern, A., Probst, L. A., Darko, W., Rosher, P., Miller, C. D., Gordon, L., & Seabury, R. W. (2019) · Hospital Pharmacy · doi:10.1177/0018578719841035 · Cited by 8
Diabetes Technology Meeting 2020
Shang, T., Zhang, J. Y., Bequette, B. W., Raymond, J. K., Coté, G. L., Sherr, J. L., Castle, J. R., Pickup, J. C., Pavlovic, Y., Espinoza, J., et al. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211016480 · Cited by 9
“206 Despite widespread adoption of this classification, data supporting Level 1 and 2 cutoffs are lacking.”
BackgroundSynthetic long-acting insulin analogs for the management of type 1 diabetes: an update
Pedersen‐Bjergaard, U., Fabricius, T. W., & Thorsteinsson, B. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1970136 · Cited by 8
Turk, N., Ramanujan, S., Shamloo, T., Craig, C., & McLaughlin, T. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf106 · Cited by 7
“Hypoglycemic events were quantified and categorized as 70, 54, and 40 mg/dL or need for third-party assistance, in line with current definitions of levels 1, 2, and 3 events [9, 10].”
Bonadonna, R. C., Yale, J., Brulle‐Wohlhueter, C., Boëlle‐Le Corfec, E., Choudhary, P., & Bailey, T. S. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13578 · Cited by 7
Santos, V. K. J. D., Prado, M. L. D. L., Silva, G. H. M. C., Aragão, I. C. S., Aragão, F. M. S., dos Santos, V. H. S., Hespanhol, L. C., de Menezes, V. L., Reis, F. P., & Aragão, J. A. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109108 · Cited by 8
Predicting hypoglycemia after treatment of hyperkalemia with insulin and glucose (Glu-K60 score)
Kijprasert, W., Tarudeeyathaworn, N., Loketkrawee, C., Pimpaporn, T., Pattarasettaseranee, P., & Tangsuwanaruk, T. (2022) · BMC Emergency Medicine · doi:10.1186/s12873-022-00748-9 · Cited by 8
Schönenberger, K. A., Ferreira, A., Stebler, C., Prendin, F., Gawinecka, J., Nakas, C. T., Mühlebach, S., Stanga, Z. G., Facchinetti, A., Herzig, D., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15175 · Cited by 9
Lin, Y. K., Ye, W., Rogers, H., Brooks, A. M., Toschi, E., Kariyawasam, D., Heller, S. R., de Zoysa, N., & Amiel, S. A. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0039 · Cited by 7
Kietaibl, A.-T., Aziz, F., Wurm, E., Tomka, C., Moser, O., Pieber, T. R., Fröhlich-Reiterer, E. E., Fasching, P., Mader, J. K., Sourij, H., et al. (2024) · Biosensors · doi:10.3390/bios14090451 · Cited by 7
Glucose Control During Labour and Delivery in Type 1 Diabetes – An Update on Current Evidence
Ringholm, L., Søholm, J. C., Pedersen, B. W., Clausen, T. D., Damm, P., & Mathiesen, E. R. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01563-1 · Cited by 8
Hollander, P. A., Kiljanski, J. I., Spaepen, E., & Harris, C. J. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13822 · Cited by 7
Blonde, L., Berard, L., Saremi, A., Huang, Y., Aroda, V. R., & Raccah, D. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00797-y · Cited by 7
Zaghlol, L. Y., Beirat, A. F., Amarin, J. Z., Najar, A. M. H. A., Hasan, Y. Y., Qtaishat, A., Tierney, M. E., Zaghlol, R. Y., & Zayed, A. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.613826 · Cited by 7
Min, J. Y., Williams, N., Simmons, W., Banerjee, S., Wang, F., Zhang, Y., Reese, A., Mushlin, A. I., & Flory, J. (2022) · Diabetic Medicine · doi:10.1111/dme.14815 · Cited by 7
Aravind, S. R., Singh, K. P., Aquitania, G. P., Mogylnytska, L., Zalevskaya, A. G., Matyjaszek‐Matuszek, B., Wernicke‐Panten, K., Nguyên‐Pascal, M., Pierre, S., Rotthaeuser, B., et al. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01255-7 · Cited by 7
Recommendations for the diagnosis and treatment of hypoglycaemia after bariatric surgery
Vilarrasa, N., Lesmes, I. B., Ballesteros-Pomar, M. D., Lecube, A., Goday, A., Pellitero, S., Sánchez‐Santos, R., Zugasti, A., Ciudin, A., de Hollanda, A., et al. (2022) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2021.09.005 · Cited by 11
Prediction of Hypoglycemia in Diabetic Patients During Colonoscopy Preparation
Lü, X., Xie, L., Zhao, W., Zhang, C., Luo, X., & Zhou, Y. (2023) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2044-0685 · Cited by 7
“0 mmol/L with or without symptoms; grade 3 (severe hypoglycemia): patients experienced disturbance of consciousness and other neurological symptoms that prominently improved or disappeared after regulation of blood glucose level [8].”
BackgroundBlack, J. E., Harris, S. B., Ryan, B. L., Zou, G., & Ratzki‐Leewing, A. A. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01423-3 · Cited by 7
Ratzki‐Leewing, A. A., Black, J. E., Ryan, B. L., Zou, G., Klar, N. S., Webster-Bogaert, S., Timcevska, K., & Harris, S. B. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15186 · Cited by 7
Fabricius, T. W., Verhulst, C. E. M., Kristensen, P. L., Holst, J. J., Tack, C. J., McCrimmon, R. J., Heller, S. R., Evans, M. L., de Galan, B. E., & Pedersen‐Bjergaard, U. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02239-8 · Cited by 10
Blunt, C., Mathew, S., Mung, S. M., Krishnamurthy, R., & Jude, E. B. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.102977 · Cited by 7
Hypoglycemia symptoms are reduced in hospitalized patients with diabetes
Criner, K. E., Kim, H. N., Ali, H., Kumar, S., Kanter, J. E., Wang, L., & Korytkowski, M. T. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107976 · Cited by 7
Honka, H., Chuang, J., D’Alessio, D. A., & Salehi, M. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab913 · Cited by 7
Verhoeff, K. K., Marfil‐Garza, B. A., Dajani, K. Z., Bigam, D. L., Anderson, B. L., Kin, T., Lam, A. P., O’Gorman, D., Senior, P. A., & Shapiro, A. M. J. (2023) · Transplantation · doi:10.1097/tp.0000000000004328 · Cited by 7
Hypoglycaemia manifestations and recurrent events: L essons from the SAVOR‐TIMI 53 outcome study
Cahn, A., Mosenzon, O., Bhatt, D. L., Leibowitz, G., Yanuv, I., Rozenberg, A., Iqbal, N., Hirshberg, B., Stahre, C., Im, K., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12903 · Cited by 7
Rokamp, K. Z., Olsen, N. V., Færch, L., Kristensen, P. L., Thorsteinsson, B., & Pedersen‐Bjergaard, U. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02739 · Cited by 8
Glycemic Control of People With Type 1 Diabetes Based on Probabilistic Constraints
Nandi, S., & Singh, T. (2018) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2018.2869365 · Cited by 7
Kamalinia, S., Josse, R. G., Donio, P. J., Leduc, L., Shah, B. R., & Tobe, S. W. (2019) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.100 · Cited by 7
Nadeau, H. C. G., Maxted, M. E., Madhavan, D., Pierce, S., Feghali, M. N., & Scifres, C. (2020) · American Journal of Perinatology · doi:10.1055/s-0040-1718579 · Cited by 8
“Hypoglycemia was defined as being mild with a glucosevalue 70 and seriouswith a glucosevalue 54mg/dL as per the International Hypoglycemia Study Group,17 and elevated fasting and postprandial valueswere defined as those 95and 140mg/dL, respectively.”
MethodZabolotskikh, I. B., Malyshev, Y. P., Вадимович, Д. П., Лебединский, К. М., Лейдерман, И. Н., Неймарк, М. И., Semenikhina, Т. М., & Yaroshetskiy, A. I. (2023) · Annals of critical care · doi:10.21320/1818-474x-2023-1-14-33 · Cited by 8
Maytham, K. B., Hagelqvist, P. G., Engberg, S., Forman, J. L., Pedersen‐Bjergaard, U., Knop, F. K., Vilsbøll, T., & Andersen, A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1352829 · Cited by 8
The impact of technology on impaired awareness of hypoglycaemia in type 1 diabetes
Berry, S. A., Goodman, I., Heller, S. R., & Iqbal, A. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251346260 · Cited by 8
Chen, Y., Pan, M. J., Wang, Q. Q., Wang, Y. H., Zhuo, H. L., & Dai, R. (2021) · Journal of Nuclear Cardiology · doi:10.1007/s12350-021-02641-7 · Cited by 6
Özkaptan, B. B., & DEMİRCİ, İ. (2023) · SDÜ Tıp Fakültesi Dergisi · doi:10.17343/sdutfd.1181696 · Cited by 6
Landgraf, W., Bigot, G., Frier, B. M., Bolli, G. B., & Owens, D. R. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2023.04.010 · Cited by 8
Taleb, N., Gingras, V., Cheng, R., Parent, V., Messier, V., Bovan, D., Shohoudi, A., Brazeau, A., & RABASA-LHORET, R. P. R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1186680 · Cited by 6
“If integrated in future artificial intelligence algorithms, these parameters could suggest adapted amounts and timings of CHO consumption (11, 16).”
BackgroundSvensson, C. H., Fabricius, T. W., Verhulst, C. E. M., Kristensen, P. L., Tack, C. J., Heller, S. R., Amiel, S. A., McCrimmon, R. J., Evans, M. L., Holst, J. J., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15649 · Cited by 7
“…by Fabricius et al. 14 These findings support the recommended hypoglycaemia level classification from the International Hypoglycaemia Study group 24 and that of the Advanced Technologies & Treatments for Diabetes for CGM 20 with respect to the clinical relevance of level 2 hypoglycaemia as…”
Modelling of glucose-insulin dynamics from low sampled data
Aradóttir, T. B., Boiroux, D., Bengtsson, H. L., & Poulsen, N. K. (2018) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2018.09.213 · Cited by 6
Kaplan, H., Amod, A., Zyl, F. H. V., Reddy, J., van Tonder, A., Tsymbal, E., & McMaster, A. (2019) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2019.1608053 · Cited by 8
Awareness of hypoglycemia and spectral analysis of heart rate variability in type 1 diabetes
Paes, T., Rolim, L. C., Filho, C. S., de Sá, J. R., & Dib, S. A. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107617 · Cited by 7
Deshmukh, H., Wilmot, E. G., Choudhary, P., Narendran, P., Shah, N. Z., Barnes, D., Kamruddin, S., Banatwalla, R., Christian, P., Saunders, S., et al. (2021) · Diabetes Care · doi:10.2337/dc21-1181 · Cited by 6
Lambert-Obry, V., Lafrance, J., Savoie, M., & Lachaîne, J. (2022) · JMIR Research Protocols · doi:10.2196/35461 · Cited by 6
Shigiyama, F., Kumashiro, N., Fuchigami, A., & Hirose, T. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0730-z · Cited by 8
Mathioudakis, N. N., Bashura, H., Lewis-Boyér, L., Langan, S. J., Padmanaban, B. S., Fayzullin, S., Sokolinsky, S., & Golden, S. H. (2019) · Journal of Medical Education and Curricular Development · doi:10.1177/2382120519861342 · Cited by 6
Evaluation of the Efficacy of a Hypoglycemia Protocol to Treat Severe Hypoglycemia
Gilmore, L., Freeman, S., Amarasekara, S., Maza, A., & Setji, T. L. (2022) · Clinical Nurse Specialist · doi:10.1097/nur.0000000000000678 · Cited by 8
Song, S. H., & Frier, B. M. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15170 · Cited by 5
Pei, Y., Ke, W., Lü, J., Lin, Y., Zhang, Z., Peng, Y., Bi, Y., Li, Y., Hou, J., Zhang, X., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0234 · Cited by 5
Lin, Y. K., Aikens, J. E., de Zoysa, N., Hall, D., Funnell, M. M., Nwankwo, R. B., Kloss, K., DeJonckheere, M. J., Pop‐Busui, R., Piatt, G., et al. (2023) · JMIR Formative Research · doi:10.2196/50374 · Cited by 6
“…[23,34] indicate that about a quarter of people with T1D who use advanced diabetes technologies continue to spend ≥ 1% of time with glucose 54 mg/dL (ie, above the recommended target [35]) or develop severe hypoglycemia (ie, episodes requiring assistance from other people for management [36]).”
BackgroundSong, S. H., & Frier, B. M. (2024) · Diabetic Medicine · doi:10.1111/dme.15466 · Cited by 5
Xu, L., Sun, X., Wang, N., Wang, Y., Yan, L., & Zhang, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-88073-6 · Cited by 7
“Moreover, the healthy values were between 3.9 and 6.1 mmol/L, and level 2 hypoglycemia was defined as hypoglycemia less than 3.0 mmol/L according to the classification of hypoglycemia 18,19 .”
InfluentialRiddle, M. C., Bolli, G. B., Avogaro, A., Álvarez, M. G., Merino‐Trigo, A., Corfec, E. B., & Home, P. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.12.001 · Cited by 5
Reddy, M., & Oliver, N. S. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0477 · Cited by 5
Association between estimated GFR and incident hypoglycaemia during hospitalization
Khanimov, I., Zingerman, B. V., Korzetz, A., Boaz, M., Shimonov, M., Wainstein, J., & Leibovitz, E. (2021) · Nephrology · doi:10.1111/nep.13984 · Cited by 5
Антонова, К. В., Лагода, О. В., & Tanashyan, M. М. (2022) · Diabetes Mellitus · doi:10.14341/dm12840 · Cited by 7
Ferreira, A., Emara, A. F., Herzig, D., Melmer, A., Vogt, A. P., Nakas, C. T., Facchinetti, A., Man, C. D., & Bally, L. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-060668 · Cited by 5
Ruan, Y., Mercuri, L., Papadimitriou, D., Galdikas, A., Roadknight, G., Davies, J., Glampson, B., Mayer, E. K., Hill, N. E., & Rea, R. D. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108474 · Cited by 5
Ma, S., ALVEAR, A. C., Schreiner, P. J., Seaquist, E. R., Kirsh, T., & Chow, L. S. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231184497 · Cited by 5
Experimental pharmacological approaches to reverse impaired awareness of hypoglycemia—a review
Hashmi, H. Z., Khowaja, A. A., & Moheet, A. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1349004 · Cited by 5
“Lastly, level 3 hypoglycemia is de fi ned as a severe event characterized by altered mental and/or physical status requiring assistance for the treatment of hypoglycemia (Heller, 2017).”
Background10th Annual Symposium on Self-Monitoring of Blood Glucose, April 27–29, 2017, Warsaw, Poland
Parkin, C. G., Homberg, A., & Hinzmann, R. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0356 · Cited by 6
Thomakos, P., Mitrakou, A., Kepaptsoglou, O., Taraoune, I., Barreto, C., & Zoupas, C. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0889-7598 · Cited by 5
Rokicka, D., Marek, B., Kajdaniuk, D., Wróbel, M. P., Szymborska‐Kajanek, A., Ogrodowczyk-Bobik, M., Urbanek, A., Janyga, S., Borgiel−Marek, H., & Strojek, K. (2019) · Endokrynologia Polska · doi:10.5603/ep.a2019.0020 · Cited by 10
Improving inpatient glycemic control by diabetes education program in internal medicine residents
Sriphrapradang, C., Mongkolrattanakul, P., Tanasanitkul, H., & Reutrakul, S. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.029 · Cited by 5
Eleftheriadou, I., Didangelos, T., Pappas, A. C., Anastasiou, E., Vasilopoulos, C., Zoupas, C., Manes, C., Tsatsoulis, A. A., Benroubi, M., Pangalos, E., et al. (2019) · HORMONES · doi:10.1007/s42000-019-00153-1 · Cited by 5
Metadata
- Authors
- International Hypoglycaemia Study Group
- Corresponding author
- International Hypoglycaemia Study Group
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-11-10
- Volume
- 40
- Issue
- 1
- Pages
- 155-157
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4247704066
- Cited by
- 608
- References
- 24
- Citations by year
- 2026: 34 · 2025: 37 · 2024: 50 · 2023: 61 · 2022: 76 · 2021: 60 · 2020: 93 · 2019: 86 · 2018: 73 · 2017: 36 · 2016: 2
- FWCI
- 55.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0515-10079)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- hypoglycemia, glucose concentration, hypoglycemic events, clinical trial reporting, hypoglycemia definition, European Association for the Study of Diabetes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.